SATURDAY, Jan. 7, 2023 -- Travel can be fun, but taxing. As the pandemic ebbs and people venture back out into the world, an expert from Baylor College of Medicine in Houston offers tips for ensuring a healthier, more peaceful vacation or work...
FRIDAY, Jan. 6, 2023 -- The U.S. Food and Drug Administration on Friday approved a second drug for Alzheimer disease, Leqembi (lecanemab-irmb), despite reports of rare brain bleeds linked to use of the drug in some patients. Leqembi, made by Eisai...
FRIDAY, Jan. 6, 2023 -- The U.S. Food and Drug Administration on Friday approved a second drug for Alzheimer disease, Leqembi (lecanemab-irmb), despite reports of rare brain bleeds linked to use of the drug in some patients. Leqembi, made by Eisai...